rs267607053
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PS1_ModeratePM1PM2PP5_Very_Strong
The NM_003060.4(SLC22A5):c.1324_1325delGCinsAT(p.Ala442Ile) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Likely pathogenic (★★). Another nucleotide change resulting in the same amino acid substitution has been previously reported as Likely pathogenic in UniProt.
Frequency
Consequence
NM_003060.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 14 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Renal carnitine transport defect Pathogenic:7Uncertain:1
- -
- -
This sequence change replaces alanine, which is neutral and non-polar, with isoleucine, which is neutral and non-polar, at codon 442 of the SLC22A5 protein (p.Ala442Ile). This variant is present in population databases (rs267607053, gnomAD 0.001%). This missense change has been observed in individual(s) with primary carnitine deficiency and systemic carnitine deficiency (PMID: 20027113, 21922592, 28841266). ClinVar contains an entry for this variant (Variation ID: 6428). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. For these reasons, this variant has been classified as Pathogenic. -
- -
Variant summary: SLC22A5 c.1324_1325delinsAT (p.Ala442Ile) results in a non-conservative amino acid change in the encoded protein sequence. Three of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 3.8e-05 in 1614054 control chromosomes. This frequency is not significantly higher than estimated for a pathogenic variant in SLC22A5 causing Systemic Primary Carnitine Deficiency (3.8e-05 vs 0.0046), allowing no conclusion about variant significance. c.1324_1325delinsAT has been reported in the literature in the homozygous and compound heterozygous states in individuals affected with Systemic Primary Carnitine Deficiency (e.g. Frigeni_2017, El-Hattab_2010, Ambroze_2022). These data indicate that the variant is likely to be associated with disease. At least one publication reports experimental evidence that this variant causes reduced carnitine transport activity in vitro and in vivo (e.g. Frigeni_2017). The following publications have been ascertained in the context of this evaluation (PMID: 36109795, 20027113, 28841266). ClinVar contains an entry for this variant (Variation ID: 6428). Based on the evidence outlined above, the variant was classified as pathogenic. -
- -
- -
- -
Inborn genetic diseases Pathogenic:1
The c.1324_1325delGCinsAT (p.A442I) alteration, located in coding exon 8 of the SLC22A5 gene, results from an in-frame deletion of GC and insertion of AT at nucleotide positions 1324 to 1325. This results in the substitution of the alanine residue for an isoleucine residue at codon 442. Based on data from gnomAD, the AT allele has an overall frequency of 0.0006% (3/282876) total alleles studied. The highest observed frequency was 0.002% (3/129190) of European (non-Finnish) alleles. This variant has been identified in the homozygous state and in conjunction with other SLC22A5 variants in individuals with features consistent with systemic primary carnitine deficiency; in at least one instance, the variants were identified in trans (Ambrose, 2022; El-Hattab, 2010; Frigeni, 2017). This amino acid position is well conserved in available vertebrate species. In an assay testing SLC22A5 function, this variant showed a functionally abnormal result (Frigeni, 2017). Based on the available evidence, this alteration is classified as likely pathogenic. -
not provided Pathogenic:1
Published functional studies demonstrate a damaging effect based on significantly reduced carnitine transport (PMID: 21922592); Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 20027113, 20574985, 21922592, 28841266) -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at